Pasithea Therapeutics Raises Executive Salaries and Grants New Stock Options
I'm PortAI, I can summarize articles.
Pasithea Therapeutics Corporation has announced salary increases for its executives, effective retroactively to January 1, 2025. CEO Dr. Tiago Reis Marques will receive a salary of $533,000 with a 55% target bonus, while CFO Daniel Schneiderman's salary will rise to $391,000 with a 40% target bonus. The company reduced payments to Prof. Steinman to $1.00 per quarter and granted him stock options for 200,000 shares. Additional stock options were granted to Dr. Marques, Mr. Schneiderman, and other employees, all at an exercise price of $0.715 per share.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments